Vitiligo trials in China
20 of 23 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleMelanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo
- Where
- Shenzhen
- Age
- 18 years to 65 years
- People
- 60
- Run by
- Hudson Biotech
See details and how to joinNCT07437560 - Phase 2Taking peopleA Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
- Where
- Beijing, Guangzhou, Shanghai, Tianjin, Wuhan
- Age
- 18 years to 99 years
- People
- 210 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07431177 · EU 2025-522301-37-00 - Phase 2Taking peopleA Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
- Where
- Beijing, Hangzhou, Shanghai, Shenzhen
- Age
- 18 years to 75 years
- People
- 66 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07533019 · EU 2025-524726-18-00 - Phase 3Not yet taking people in ChinaA Phase 3 Study of Povorcitinib Phosphate in Chinese Adults With Nonsegmental Vitiligo
- Where
- Beijing, Changchun, Changde, Chengde, Chengdu, Chongqing, Dalian, Guangzhou, Hangzhou, Hefei, Jiangmen, Jinan, Jingzhou, Kunming, Nanchang, Nanning, Nanyang, Ningbo, Sanmenxia, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Suzhou, Taiyuan, Ürümqi, Wuhan, Xi'an, Xingtai, Zhengzhou, Zhenjiang
- Age
- 18 years and over
- People
- 174
- Run by
- Dermavon Holdings Limited
See details and how to joinNCT07865312 - Phase 2/3Not yet taking people in ChinaPhase II/III Study of FXS5626 in Participants With Non-segmental Vitiligo
- Where
- Shanghai
- Age
- 12 years to 75 years
- People
- 480
- Run by
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
See details and how to joinNCT07840820 - Phase 1/2Not yet taking people in ChinaA Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo
- Where
- Beijing
- Age
- 12 years to 18 years
- People
- 10
- Run by
- Jiangsu vcare pharmaceutical technology co., LTD
See details and how to joinNCT07828639 - Phase 3Taking peopleA Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo
- Where
- Beijing
- Age
- 12 years to 75 years
- People
- 405
- Run by
- Minghui Pharmaceutical (Hangzhou) Ltd
See details and how to joinNCT07682506 - Phase 2Taking peopleA Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of QY201 Tablets in Subjects With Non-Segmental Vitiligo
- Where
- Shenyang
- Age
- 18 years to 65 years
- People
- 200
- Run by
- E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.
See details and how to joinNCT07712523 - Phase 2Taking peopleStudy of D-2570 in Subjects With Non-Segmental Vitiligo
- Where
- Shanghai
- Age
- 18 years to 65 years
- People
- 160
- Run by
- InventisBio Co., Ltd
See details and how to joinNCT07625891 - Phase 3Not yet taking people in ChinaEfficacy and Safety of Ruxolitinib Cream in Chinese Children Aged 2-11 Years With Non-segmental Vitiligo
- Where
- Hangzhou
- Age
- 2 years to 11 years
- People
- 20
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07595939 - Phase 1Taking peopleStudy to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 160
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07554222 - Phase 1/2Not yet taking people in ChinaStudy of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo
- Where
- Xi'an
- Age
- 18 years to 65 years
- People
- 96
- Run by
- Xijing Hospital
See details and how to joinNCT07519031 - Phase 2Taking peopleA Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo
- Where
- Jinan
- Age
- 18 years to 75 years
- People
- 176
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07251595 - No phaseNot yet taking people in ChinaNevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study
- Where
- Xi'an
- Age
- 6 years to 45 years
- People
- 60
- Run by
- Xijing Hospital
See details and how to joinNCT07307534 - Phase 2Taking peopleEfficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 120
- Run by
- Jiangsu vcare pharmaceutical technology co., LTD
See details and how to joinNCT07172347 - No phaseTaking peopleAutologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo
- Where
- Beijing
- Age
- 8 years to 65 years
- People
- 30
- Run by
- Peking University People's Hospital
See details and how to joinNCT07187882 - Phase 2/3Taking peopleICP-332 in Subjects With Non-segmental Vitiligo
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hengyang, Jinan, Jingzhou, Kunming, Lianyungang, Luoyang, Nanchang, Nanjing, Nanyang, Ningbo, Shanghai, Shenyang, Shijiazhuang, Shiyan, Suzhou, Weihui, Wenzhou, Wuhan, Wuhu, Xian, Yiwu, Zhengzhou, Zibo
- Age
- 12 years to 75 years
- People
- 603
- Run by
- Beijing InnoCare Pharma Tech Co., Ltd.
See details and how to joinNCT07047612 - No phaseTaking peopleOral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCT
- Where
- Xi'an
- Age
- 4 years to 12 years
- People
- 90
- Run by
- Xijing Hospital
See details and how to joinNCT06900777 - Early phase 1Not yet taking people in ChinaInduced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Stable Vitiligo
- Where
- Wuhu
- Age
- 18 years to 60 years
- People
- 29
- Run by
- Second Affiliated Hospital of Wannan Medical College
See details and how to joinNCT06810869 - No phaseTaking peopleEfficacy of Upadacitinib After NECS in Vitiligo
- Where
- Changchun
- Age
- 18 years to 60 years
- People
- 60
- Run by
- Jilin University
See details and how to joinNCT06454461